CollPlant Biotechnologies (CLGN) EBIT (QoQ) (2018 - 2026)
CollPlant Biotechnologies (CLGN) EBIT (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 1.11% |
| Dec 31, 2025 | 10.18% |
| Sep 30, 2025 | -210.35% |
| Jun 30, 2025 | 292.84% |
| Mar 30, 2025 | 58.53% |
| Dec 31, 2024 | 12.51% |
| Sep 30, 2024 | -203.09% |
| Jun 30, 2024 | 1.78% |
| Mar 31, 2024 | 185.42% |
| Dec 31, 2023 | -10.13% |
| Sep 30, 2023 | -181.06% |
| Jun 30, 2023 | 61.32% |
| Mar 31, 2023 | 175.26% |
| Dec 31, 2022 | -4.66% |
| Sep 30, 2022 | -6.76% |
| Jun 30, 2022 | -211.07% |
| Mar 31, 2022 | 199.05% |
| Dec 31, 2021 | -22.95% |
| Sep 30, 2021 | -1.01% |
| Jun 30, 2021 | -130.55% |